However, recent reports of PNH arising in the setting of a CALR-mutated MPN [50],CML [51] and a relapse of AML associated with TET2 and JAK2 mutations [52] raise the question of whether autoimmunity is necessary in all cases. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.